G
Gain Therapeutics, Inc. (GANX)
1.83
0.00 (0.00%)

1.83
0.00 (0.00%)
This stock has a consensus price target of $8.00 based on the ratings of 9 analysts. The high is $12.00 and the low is $6.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 6 | $ 8 | $ 12 |
| O’zgarish | 227.87% | 337.16% | 555.74% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2025-12-19 | 337.16% | HC Wainwright & Co. | $8 → $8 | Reiterates | Buy |
| 2025-10-15 | 391.8% | BTIG | $9 → $9 | Reiterates | Buy |
| 2025-10-13 | 337.16% | HC Wainwright & Co. | $8 → $8 | Reiterates | Buy |
| 2025-10-07 | 282.51% | Maxim Group | $5 → $7 | Maintains | Buy |
| 2025-09-08 | 391.8% | BTIG | $9 → $9 | Reiterates | Buy |